Current market catalysts

Morgan Stanley Downgrades Peloton Interactive to Underweight, Lowers Price Target to $4.5

Does Michael Burry Have It Wrong? Nvidia Chips Retain Value, Data Shows

Nvidia’s 6-year-old A100 chips still carry nearly $5,000 in estimated value, challenging Michael Burry’s AI depreciation warning.

HC Wainwright & Co. Maintains Buy on Roivant Sciences, Raises Price Target to $47

A Rivals Clinical Stumble Sends Sarepta Therapeutics Stock Lower

Sarepta Therapeutics shares react to Novartis Phase 3 trial results in DM1 while Sarepta progresses its SRP-1003 RNA therapy clinical trials.

Piper Sandler Maintains Overweight on Equity Bancshares, Raises Price Target to $60

Why Oracle Stock is the Trade to Watch After OpenAI's AGI Claim

Oracle's $300 billion OpenAI deal makes it an AGI infrastructure proxy. Thursday's earnings will test cloud growth and backlog conversion.

Piper Sandler Reiterates Overweight on Shopify, Raises Price Target to $180

Why Is Cipher Digital Stock Surging on Tuesday?

Cipher Digital Inc (NASDAQ: CIFR) stock is trading higher Tuesday after announcing lateral pipeline developments for high-performance computing data centers.

Stifel Maintains Buy on Hinge Health, Raises Price Target to $115

B. Riley Securities Maintains Neutral on eGain, Lowers Price Target to $6

Novartis Myotonic Dystrophy Trial Flop Sends Dyne Therapeutics Shares Tumbling

Dyne Therapeutics stock sinks on Novartis' failed Phase 3 myotonic dystrophy study, even as Dyne prepares new trial data presentations.

HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $19 Price Target

U.S. Cyber, Law Enforcement Officials Accuse Chinese AI Companies Of 'Aggressive, Industrial-Scale Distillation Activities'

United Natural Foods Plans for More Inflation in 2027, Says Productivity, Not Price Hikes, Will Drive Margins

United Natural Foods (UNFI) beats Q4 EPS estimates and issues strong FY2027 guidance. Read the full earnings and stock performance report.

Tenable Integrates Anthropic’s Claude Mythos 5 Into Tenable One For AI-Powered Exposure Management

9 Communication Services Stocks With Whale Alerts In Today’s Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often

10 Industrials Stocks With Whale Alerts In Today’s Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often

10 Information Technology Stocks Whale Activity In Today’s Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders will

What's Going On With NVIDIA Stock Tuesday?

NVIDIA (NVDA) stock fell ~2% on Tuesday to $225.90, lagging tech sector gains despite broad market strength. Read the market analysis.

Needham Reiterates Buy on BioCryst Pharma, Maintains $16 Price Target

8-K filing — Federal Home Loan Bank of Cincinnati

Filed: 2026-09-08 AccNo: 0001326771-26-000147 Size: 157 KB Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Tesla Cybercab vs. Uber: Who Wins the Robotaxi Race?

Tesla and Uber are taking very different approaches to robotaxis. Here's which strategy could win the autonomous ride-hailing race.

HC Wainwright & Co. Maintains Buy on PDS Biotechnology, Lowers Price Target to $5

Boston Scientific Says It Won't Meet 2026 Guidance After Cyberattack

Boston Scientific expects a 2026 earnings miss after a cyberattack disrupted global operations. Manufacturing and shipping are recovering.

QUICK SPARK: Amgen Stock Eyes Worst Day Since October 2000

Amgen sank 9.8% Tuesday after Novartis' pelacarsen missed its Phase 3 endpoint, casting doubt on rival Lp(a) drug olpasiran.

XRP, Bitcoin Have Moved in 'Near-Perfect Lockstep'—Here's What Could Change Soon

XRP may decouple from Bitcoin as an XRPL upgrade nears, but CPI and macro forces will test whether it can outperform independently.

HC Wainwright & Co. Maintains Buy on Sernova Biotherapeutics, Lowers Price Target to C$1

Goldman Stock Gains 38.6% in a Year: Buy Now or Wait for a Pullback?

Goldman Sachs (GS) has outperformed its industry peers with a 38.6% gain over the past year, driven by a 52% rise in investment banking fees, strong M&A activity, and ambitious AI transformation initiatives. The company's strategic streamlining, robust liquidity, and expansion in asset management support continued growth and shareholder returns. Analysts maintain a bullish outlook with upward earnings revisions, though the stock trades at a modest premium to industry peers.

Coca-Cola's Premiumization Push: Smart Strategy or Risky Move?

Coca-Cola is pursuing a balanced premiumization strategy across markets while maintaining affordability options for value-conscious consumers. The company uses brand strength, packaging variety, and occasion-based pricing to reach different income levels. However, risks remain as lower-income consumers face economic pressure globally. Peers PepsiCo and Monster Beverage are also pursuing similar premium strategies with measured approaches.

KTCC Stock Falls 35% as Q4 Loss Widens Y/Y Despite Revenue Rebound

Key Tronic Corporation (KTCC) shares fell 35.4% following Q4 fiscal 2026 results, which showed a GAAP net loss of $34.3 million despite improved gross margins. The company faced headwinds from supply chain credit constraints that delayed ~$10 million in shipments, along with a $28.4 million tax valuation allowance and $8.4 million in write-offs. However, management expects revenue growth and profitability recovery in fiscal 2027, supported by new program awards exceeding $60 million and restructuring initiatives including China exit and Vietnam expansion.